How to Choose the Right CDMO for Your Biologics Program Selecting a Contract Development and Manufacturing Organization (CDMO) is one of...
How to Choose the Right CDMO for Your Biologics Program
read more
Why HCP Monitoring Matters in Biologics
Why HCP Monitoring is Critical in Biologics Development Biologics have reshaped modern medicine, providing innovative therapies for...
5 Key Steps in GMP Cell Line Development Process
Why Cell Line Development Is Essential for Biologics Manufacturing Cell line development is one of the most critical stages in the...
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing Antibody-drug conjugates (ADCs) represent a groundbreaking class of...
Optimizing Process Development for Monoclonal Antibodies
Optimizing Process Development for Monoclonal Antibodies: Key Considerations for Clinical Success Monoclonal antibodies (mAbs) have become...
Interview – Challenges in the Development & Manufacturing of ADCs
Simone Seechi, R&D Process Chemist at Olon and Matthieu Culié, Head of Development & GMP Manufacturing at GTP Bioways were...
Choosing a Biologics CDMO: Your Blueprint for Success
In the dynamic and high-stakes world of biologics, selecting the right Contract Development and Manufacturing Organisation (CDMO) can make...
Effective Strategies for Host Cell Protein Purification: A Case Study
In the field of biomanufacturing, the challenge of host cell protein (HCP) purification remains a critical hurdle in many biotherapeutic...
